176 related articles for article (PubMed ID: 27021132)
21. A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
Ye Z; Wang C; Kijlstra A; Zhou X; Yang P
Curr Mol Med; 2014 May; 14(4):535-42. PubMed ID: 24730521
[TBL] [Abstract][Full Text] [Related]
22. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O
Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
[TBL] [Abstract][Full Text] [Related]
23. Behçet's disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations.
Perazzio SF; Soeiro-Pereira PV; de Souza AW; Condino-Neto A; Andrade LE
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S85-95. PubMed ID: 26394190
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
[TBL] [Abstract][Full Text] [Related]
25. Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.
Ozkan Y; Yardim-Akaydin S; Sepici A; Engin B; Sepici V; Simşek B
Clin Chem Lab Med; 2007; 45(1):73-7. PubMed ID: 17243919
[TBL] [Abstract][Full Text] [Related]
26. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease.
Liu X; Wang C; Ye Z; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6012-7. PubMed ID: 23908180
[TBL] [Abstract][Full Text] [Related]
27. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis.
Takeuchi M; Usui Y; Okunuki Y; Zhang L; Ma J; Yamakawa N; Hattori T; Kezuka T; Sakai J; Goto H
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3067-75. PubMed ID: 20089879
[TBL] [Abstract][Full Text] [Related]
28. Uric acid increases IL-1β secretion and Caspase-1 activation in PBMCs of Behçet's disease patients: The in vitro immunomodulatory effect of xanthine oxidase inhibitor Allopurinol.
Chekaoui A; Belguendouz H; Lahmar K; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C
Int Immunopharmacol; 2020 Mar; 80():106119. PubMed ID: 31927504
[TBL] [Abstract][Full Text] [Related]
29. Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.
Wang C; Tian Y; Ye Z; Kijlstra A; Zhou Y; Yang P
Arthritis Res Ther; 2014 May; 16(3):R117. PubMed ID: 24887071
[TBL] [Abstract][Full Text] [Related]
30. Association of Reduced Heme Oxygenase-1 with Decreased MicroRNA-196a2 Expression in Peripheral Blood Mononuclear Cells of Patients with Intestinal Behcet's Disease.
Zou J; Ji DN; Shen Y; Guan JL; Zheng SB
Ann Clin Lab Sci; 2016 Dec; 46(6):675-679. PubMed ID: 27993883
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
[TBL] [Abstract][Full Text] [Related]
32. Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker?
Evereklioglu C; Turkoz Y; Er H; Inaloz HS; Ozbek E; Cekmen M
J Am Acad Dermatol; 2002 Jan; 46(1):50-4. PubMed ID: 11756945
[TBL] [Abstract][Full Text] [Related]
33. Tear nitrite and nitrate levels as nitric oxide end products in patients with Behçet's disease and non-Behçet's uveitis.
Mirza GE; Karaküçük S; Er M; Güngörmüş N; Karaküçük I; Saraymen R
Ophthalmic Res; 2001; 33(1):48-51. PubMed ID: 11114605
[TBL] [Abstract][Full Text] [Related]
34. Effects of testosterone, 17beta-estradiol, and downstream estrogens on cytokine secretion from human leukocytes in the presence and absence of cortisol.
Janele D; Lang T; Capellino S; Cutolo M; Da Silva JA; Straub RH
Ann N Y Acad Sci; 2006 Jun; 1069():168-82. PubMed ID: 16855144
[TBL] [Abstract][Full Text] [Related]
35. Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease.
Chekaoui A; Lahmar K; Belguendouz H; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C
Eur Cytokine Netw; 2018 Sep; 29(3):95-102. PubMed ID: 30547891
[TBL] [Abstract][Full Text] [Related]
36. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
[TBL] [Abstract][Full Text] [Related]
37. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
38. Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation.
Cuchacovich M; Merino G; Yamamoto JH; Villarroel F; Saavedra T; Jofre S; Gatica H; Velasquez V; Pizzo SV; Gonzalez-Gronow M
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S27-34. PubMed ID: 16273761
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 (IL-6) in patients with Behçet's disease.
Yamakawa Y; Sugita Y; Nagatani T; Takahashi S; Yamakawa T; Tanaka S; Nakamura S; Ohno S; Sekihara H; Okuda K; Nakajima H
J Dermatol Sci; 1996 Mar; 11(3):189-95. PubMed ID: 8785169
[TBL] [Abstract][Full Text] [Related]
40. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease.
Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N
Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
